159 related articles for article (PubMed ID: 35113353)
21. [Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors].
Lorch A; Oechsle K; Bokemeyer C; Beyer J
Urologe A; 2009 Apr; 48(4):364-71. PubMed ID: 19255738
[TBL] [Abstract][Full Text] [Related]
22. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel, ifosfamide and cisplatin (TIP) beyond its original indication for salvage treatment of germ cell tumors.
Voss MH; Feldman DR
Onkologie; 2011; 34(8-9):410-1. PubMed ID: 21934338
[No Abstract] [Full Text] [Related]
24. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
Pizzocaro G; Guarneri A
Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
[No Abstract] [Full Text] [Related]
25. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
[TBL] [Abstract][Full Text] [Related]
26. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
[TBL] [Abstract][Full Text] [Related]
27. Role of one, two and three doses of high-dose chemotherapy with autologous transplantation in the treatment of high-risk or relapsed testicular cancer: a systematic review.
Bin Riaz I; Umar M; Zahid U; Husnain M; Iftikhar A; McBride A; Bilal J; Javed A; Akbar S; Singh P; Ali Z; Sipra QUAR; Gondal FR; Ahman F; Anwer F
Bone Marrow Transplant; 2018 Oct; 53(10):1242-1254. PubMed ID: 29703969
[TBL] [Abstract][Full Text] [Related]
28. A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
Rodenhuis S; de Wit R; de Mulder PH; Keizer HJ; Sleijfer DT; Lalisang RI; Bakker PJ; Mandjes I; Kooi M; de Vries EG
Ann Oncol; 1999 Dec; 10(12):1467-73. PubMed ID: 10643538
[TBL] [Abstract][Full Text] [Related]
29. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
[TBL] [Abstract][Full Text] [Related]
30. Salvage therapy in recurrent germ cell cancer.
Loehrer PJ
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1211-21. PubMed ID: 1663940
[TBL] [Abstract][Full Text] [Related]
31. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
[TBL] [Abstract][Full Text] [Related]
32. Salvage therapy in recurrent testicular cancer.
Saxman S
Semin Oncol; 1992 Apr; 19(2):143-7. PubMed ID: 1372756
[TBL] [Abstract][Full Text] [Related]
33. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J
J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152
[TBL] [Abstract][Full Text] [Related]
34. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
35. Leptomeningeal carcinomatosis in relapsed non-seminoma testis: a 1-year complete remission with high-dose chemotherapy.
Denissen NH; van Spronsen DJ; Smilde TJ; De Mulder PH
Anticancer Drugs; 2005 Sep; 16(8):897-9. PubMed ID: 16096440
[TBL] [Abstract][Full Text] [Related]
36. Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Rashid S; Lim L; Powles T
Curr Treat Options Oncol; 2012 Jun; 13(2):201-11. PubMed ID: 22623055
[TBL] [Abstract][Full Text] [Related]
37. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
[TBL] [Abstract][Full Text] [Related]
38. [High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Lorch A; Albers P; Winter C; Beyer J
Urologe A; 2011 Sep; 50(9):1047-54. PubMed ID: 21845425
[TBL] [Abstract][Full Text] [Related]
39. Promising novel therapies for relapsed and refractory testicular germ cell tumors.
Kozakova K; Mego M; Cheng L; Chovanec M
Expert Rev Anticancer Ther; 2021 Jan; 21(1):53-69. PubMed ID: 33138660
[TBL] [Abstract][Full Text] [Related]
40. Intensive and timely chemotherapy, the key of success in testicular cancer.
Fléchon A; Culine S; Droz JP
Crit Rev Oncol Hematol; 2001 Jan; 37(1):35-46. PubMed ID: 11164717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]